Ac-yvad-cho

1 study on Ac-yvad-cho curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.

Bottom line: TitrateLab currently curates 1 dated study on Ac-yvad-cho. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.

Ac-yvad-cho studies and clinical research

2026-04-06 PubMed · other

Caspase-1 Inhibitors Show Broad Efficacy in Multisystem Inflammatory Diseases

This comparative study provides compelling evidence that caspase-1 inhibition is a highly effective therapeutic strategy for mitigating inflammation and tissue damage in complex multisystem diseases like IBD and NASH.…

Research tools

Free, no account — handy when you're working with Ac-yvad-cho.

Reconstitution calculator Bac water, concentration & insulin-unit math Verify a COA Look up a report number against our corpus

TitrateLab PRO

Unlock the complete evidence trail

Pro members save studies and unlock the full evidence breakdown and vendor lab data.

Complete vendor lab histories
Every linked certificate on file
Batch-level purity and quantity detail
Thousands of community reviews

Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.

$12 monthly or $33 lifetime

Create free account

TitrateLab

You must be 21 or older to enter.

TitrateLab provides research-use information on peptides for adults. Confirm your age to continue.

For research purposes only. Not for human consumption. By entering you agree to our Terms & Privacy.

Ac-yvad-cho studies and clinical research

Caspase-1 Inhibitors Show Broad Efficacy in Multisystem Inflammatory Diseases

Research tools